Skip to main content
. 2015 Feb 1;2015:592512. doi: 10.1155/2015/592512

Table 1.

Patient characteristics and clinical parameters.

HTx-CTRL (n = 9) HTx-LVAD (n = 8)
Pre-LVAD Post-LVAD
Age (years), mean ± SE 52 ± 3 46 ± 4
Male gender (n) 5 8
Duration of LVAD assistance (days), mean ± SE 357 ± 66
Ischemic heart disease (IHD) (n) 2 1

Cardiac index (L/min/m2), mean ± SE 1.90 ± 0.17 1.61 ± 0.13 2.82 ± 0.30#∗∗
PCWP (mm Hg), mean ± SE 14 ± 3 24 ± 5 9 ± 3*
PASP (mm Hg), mean ± SE 33 ± 4 47 ± 6 27 ± 3*
PADP (mm Hg), mean ± SE 13 ± 2 23 ± 3 12 ± 4*
LVEF (%), mean ± SE 26 ± 2 21 ± 2 28 ± 3*
LVESV (mL), mean ± SE 147 ± 17 282 ± 27 160 ± 20**
LVEDV (mL), mean ± SE 196 ± 18 357 ± 32§ 219 ± 18**
LVEDD (mm), mean ± SE 66 ± 2 80 ± 3§ 70 ± 3*
NT-proBNP (ng/L), mean ± SE 2976 ± 1562 4800 ± 991 576 ± 145**

# P < 0.05 versus HTx-CTRL; P < 0.01 versus HTx-CTRL; § P < 0.001 versus HTx-CTRL; * P < 0.05 versus pre-LVAD; ** P < 0.01 versus pre-LVAD.

PCWP: pulmonary capillary wedge pressure; PASP: pulmonary artery systolic pressure; PADP: pulmonary artery diastolic pressure; LVEF: left ventricular ejection fraction; LVESV: left ventricular end-systolic volume; LVEDV: left ventricular end-diastolic volume; LVEDD: left ventricular end-diastolic diameter; NT-proBNP: N-terminal prohormone of brain natriuretic peptide.